Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusSkin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusActive, not recruitingPhase 22026-07-21NCT05966480

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Alumis Inc3

169 results · Page 1 of 7

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Investigator Site # 2517NaucalpanMexico1
Investigator Site # 6015New DelhiIndia1
Investigator Site #1044MemphisUnited States1
Investigator Site #1045ClearwaterUnited States1
Investigator Site #1046AnnistonUnited States1
Investigator Site #1048AventuraUnited States1
Investigator Site #1049ColleyvilleUnited States1
Investigator Site #1050Los AlamitosUnited States1
Investigator Site #1051DeBaryUnited States1
Investigator Site #1052College ParkUnited States1
Investigator site #1053San AntonioUnited States1
Investigator Site #1055Coral GablesUnited States1
Investigator Site #1056CharlotteUnited States1
Investigator Site #1057MiamiUnited States1
Investigator Site #1058BrooklynUnited States1
Investigator Site #1060MiamiUnited States1
Investigator Site #1061UplandUnited States1
Investigator Site #1062PittsburghUnited States1
Investigator Site #1063Avon ParkUnited States1
Investigator Site #1067Miami LakesUnited States1
Investigator Site #1071Fort WorthUnited States1
Investigator Site #1087HollywoodUnited States1
Investigator Site #1088New YorkUnited States1
Investigator Site #1089TampaUnited States1
Investigator Site #1090PlantationUnited States1